San Ching, Nguyen Quang Thieu, Phan Thi Thuy Quyen, Nguyen An Khang, Nguyen Kim Ngan, To Thi Hong Phuong, Pham Phuc Thinh, Nguyen Viet Hai
{"title":"PS10-14. The Effect of Varium® on Growth Performance, Gut Microbiome, and Health of Growing Pigs.","authors":"San Ching, Nguyen Quang Thieu, Phan Thi Thuy Quyen, Nguyen An Khang, Nguyen Kim Ngan, To Thi Hong Phuong, Pham Phuc Thinh, Nguyen Viet Hai","doi":"10.1093/jas/skag272.523","DOIUrl":null,"url":null,"abstract":"Varium® was developed as an alternative to antibiotic-growth-promoters, containing minerals, organic acids, and yeast specifically designed to improve gut health in production animals. The objective of this study was to test the effect of Varium on growth performance, gut microbiome, and the overall health of growing pigs. A total of 200 growing pigs (Duroc X [Landrace X Yorkshire], at 70 days old (25.39 ± 4 kg) were used in this experiment and separated between two treatments. The first treatment was the designated control (CON), with the growing pigs fed a standard diet without Varium. The second treatment (VAR) included the control diet supplemented with Varium at a dosage of 1kg per ton of feed. There were 4 replicates (pens) in each treatment with 25 pigs per pen. Basal diets were formulated in mash form to meet the recommendation of the farm. The feeding program consisted of Phase I from days 1 to 28 of the trial and Phase II from days 29 to 50. Body weight measurements were taken on days 1, 28, and 50 of the trial, while feed consumption was measured daily to analyze growth performance. Mortality and diarrhea incidence were also recorded daily. The experiment was conducted as a completely randomized design with data analyzed by GLM procedures of Minitab 17. Treatment differences were measured via the Tukey test with differences of P < 0.05 as significant. The results showed average daily gains in VAR were numerically higher than that of CON on day 1, 28, and 50 with 498 vs. 492; 841 vs. 796; 649 vs. 626 g, respectively (P > 0.05). Average feed intake slightly decreased in VAR compared to CON during these 3 periods with 1115 vs. 1115; 1844 vs. 1927; 1438 vs. 1480, respectively (P > 0.05). This resulted in numerically improved feed conversions in VAR during these periods with 2.236 vs. 2.328; 2.181 vs. 2.518; 2.209 vs. 2.379, respectively (P > 0.05). During the trial period disease incidence was lower in VAR than in CON from day 1-28 (14.2 to 15.6, P = 0.185), significantly lower from day 29-50 (2.0 to 6.5, P < 0.05), and significantly lower from day 1-50 (9.1 to 12.1, P < 0.05). Reductions in E. coli population (log 6.27 vs. 6.59, P = 0.174) and an increase in Lactobacillus population (log 9.09 vs. 8.95, P = 0.487) were observed numerically in VAR when compared to CON. When analyzing improvements in these key metrics, an 8.71% better economic return was seen in VAR than CON. In conclusion, the addition of Varium at 1 kg/MT in the diet of growing pigs tends to improve growth performance, promotes microbiome balance, and significantly reduces disease incidence throughout the growth phase.","PeriodicalId":14895,"journal":{"name":"Journal of animal science","volume":"32 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of animal science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1093/jas/skag272.523","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AGRICULTURE, DAIRY & ANIMAL SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
Varium® was developed as an alternative to antibiotic-growth-promoters, containing minerals, organic acids, and yeast specifically designed to improve gut health in production animals. The objective of this study was to test the effect of Varium on growth performance, gut microbiome, and the overall health of growing pigs. A total of 200 growing pigs (Duroc X [Landrace X Yorkshire], at 70 days old (25.39 ± 4 kg) were used in this experiment and separated between two treatments. The first treatment was the designated control (CON), with the growing pigs fed a standard diet without Varium. The second treatment (VAR) included the control diet supplemented with Varium at a dosage of 1kg per ton of feed. There were 4 replicates (pens) in each treatment with 25 pigs per pen. Basal diets were formulated in mash form to meet the recommendation of the farm. The feeding program consisted of Phase I from days 1 to 28 of the trial and Phase II from days 29 to 50. Body weight measurements were taken on days 1, 28, and 50 of the trial, while feed consumption was measured daily to analyze growth performance. Mortality and diarrhea incidence were also recorded daily. The experiment was conducted as a completely randomized design with data analyzed by GLM procedures of Minitab 17. Treatment differences were measured via the Tukey test with differences of P < 0.05 as significant. The results showed average daily gains in VAR were numerically higher than that of CON on day 1, 28, and 50 with 498 vs. 492; 841 vs. 796; 649 vs. 626 g, respectively (P > 0.05). Average feed intake slightly decreased in VAR compared to CON during these 3 periods with 1115 vs. 1115; 1844 vs. 1927; 1438 vs. 1480, respectively (P > 0.05). This resulted in numerically improved feed conversions in VAR during these periods with 2.236 vs. 2.328; 2.181 vs. 2.518; 2.209 vs. 2.379, respectively (P > 0.05). During the trial period disease incidence was lower in VAR than in CON from day 1-28 (14.2 to 15.6, P = 0.185), significantly lower from day 29-50 (2.0 to 6.5, P < 0.05), and significantly lower from day 1-50 (9.1 to 12.1, P < 0.05). Reductions in E. coli population (log 6.27 vs. 6.59, P = 0.174) and an increase in Lactobacillus population (log 9.09 vs. 8.95, P = 0.487) were observed numerically in VAR when compared to CON. When analyzing improvements in these key metrics, an 8.71% better economic return was seen in VAR than CON. In conclusion, the addition of Varium at 1 kg/MT in the diet of growing pigs tends to improve growth performance, promotes microbiome balance, and significantly reduces disease incidence throughout the growth phase.
Varium®是作为抗生素生长促进剂的替代品而开发的,它含有矿物质、有机酸和酵母,专门用于改善生产动物的肠道健康。本研究的目的是测试varum对生长猪的生长性能、肠道微生物群和整体健康的影响。试验选用70日龄(25.39±4 kg)的杜洛克X[长白X大约克]生长猪200头,分为2个处理。第一个处理是指定对照(CON),给生长猪喂食不含Varium的标准日粮。第二组试验为在对照饲粮中添加varum,剂量为每吨饲料1kg。每个处理4个重复(栏),每个栏25头猪。基础饲粮以醪形式配制,以满足养殖场的推荐。试验第1 ~ 28天为第一阶段,第29 ~ 50天为第二阶段。分别于试验第1、28和50天测定体重,并每日测定采食量以分析生长性能。每天还记录死亡率和腹泻发生率。实验采用完全随机设计,数据采用Minitab 17的GLM程序进行分析。处理差异采用Tukey检验,P <;0.05为显著性。结果显示,VAR在第1、28和50天的平均日收益在数字上高于CON,分别为498比492;841 vs. 796;分别为649和626 g (P > 0.05)。在这3个时期,VAR的平均采食量比CON略有下降(1115比1115);1844 vs. 1927;1438 vs. 1480 (P > 0.05)。这导致在这些时期VAR的饲料转换在数字上有所改善,分别为2.236 vs. 2.328;2.181 vs. 2.518;2.209 vs. 2.379 (P > 0.05)。在试验期间,VAR组的疾病发病率在第1-28天低于CON组(14.2 ~ 15.6,P = 0.185),在第29-50天显著低于CON组(2.0 ~ 6.5,P < 0.05),在第1-50天显著低于CON组(9.1 ~ 12.1,P < 0.05)。与对照组相比,VAR的大肠杆菌数量减少了(log 6.27 vs. 6.59, P = 0.174),乳酸杆菌数量增加了(log 9.09 vs. 8.95, P = 0.487)。在分析这些关键指标的改善时,VAR的经济回报比con高8.71%。综上所示,在生长猪日粮中添加1 kg/MT的varum有利于提高生长性能,促进微生物群平衡,并显著降低整个生长阶段的发病率。
期刊介绍:
The Journal of Animal Science (JAS) is the premier journal for animal science and serves as the leading source of new knowledge and perspective in this area. JAS publishes more than 500 fully reviewed research articles, invited reviews, technical notes, and letters to the editor each year.
Articles published in JAS encompass a broad range of research topics in animal production and fundamental aspects of genetics, nutrition, physiology, and preparation and utilization of animal products. Articles typically report research with beef cattle, companion animals, goats, horses, pigs, and sheep; however, studies involving other farm animals, aquatic and wildlife species, and laboratory animal species that address fundamental questions related to livestock and companion animal biology will be considered for publication.